GSK Makes ADC Pipeline Comeback With Mersana Deal

Pays $100m Upfront

 
• By Ayisha Sharma
  
Purple Cells
GSK Already Has One ADC Product On The Market For Multiple Myeloma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip